Sanofi iAwards North America

“More than just providing research support, the iAward program catalyzed a meaningful collaboration between my lab and Sanofi, with genuine intellectual exchange of ideas and resources around our shared scientific interests in neuroimmune and neurodegenerative disease. The program enabled Sanofi scientists to engage early with cutting-edge, unpublished discoveries from our lab, while providing us with valuable industry perspective on translational challenges and opportunities. It also had a strong impact on trainee development, as students in my lab gained direct exposure to industry scientists and were actively involved in the project. Together, this collaboration advanced our science toward translational insights with the potential to inform future therapeutic strategies.”

J. Bradley Zuchero, PhD, Associate Professor of Neurosurgery, Covert-Matera Families Endowed Faculty Scholar, Stanford University School of Medicine

"I am pleased by the continued partnership between the Perelman School of Medicine at the University of Pennsylvania and Sanofi, in particular the success of the Sanofi iAwards. Our investigators appreciate the opportunity to collaborate with Sanofi scientists and leadership on cutting-edge, scientific ideas - advancing the innovative work from concept to application. As a JSSC member, I am delighted to foster this partnership and support the program's growth, not only at Penn, but accross the U.S."

Jonathan A. Epstein, M.D., Executive Vice Dean and Chief Scientific Officer, William Wikoff Smith Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania, Sanofi iAwards External Joint Scientific Steering Commitee Member

“Thanks to the iAwards program, we joined forces with the bright team of scientists at Sanofi to propel the field of non-invasive gene delivery to the brain. It is incredibly stimulating and productive, generating exciting discoveries with translational potential. The collective knowledge and expertise made possible through this continued collaborative partnership could transform the future gene therapy for patients with neurological disorders.”

Isabelle Aubert, Senior Scientist, Biological Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute Sunnybrook Research Institute, University of Toronto

“The program enables advancing scientifically novel yet risky projects, that if successful, could produce transformative medicines. The financial support, expertise and reagents from Sanofi as part of this collaboration is critical for advancing novel bench side discoveries to the clinic.”

Vijay Kuchroo, Ph.D., Samuel L. Wasserstrom professor of Neurology at Harvard medical School, Co-Director of the Center for Injection and Immunity, Brigham Research Institutes, Boston, Associate Member of the Broad Institute

“The iAwards program is a fantastic opportunity and partnership to move forward a small molecule technology with a leading pharmaceutical company in the oncology space. The scientists involved with the Sanofi iAwards program are completely invested in the science and their insight is crucial to understanding the science and the technology.”

Nicolas Nassar, PhD, Cincinnati Children’s Hospital

"Our iAwards program collaborates with top academic innovators to quickly bring early-stage value creating projects to Sanofi’s research pipeline. About 40% of our iAwards projects convert into multi-year Sponsored Research Agreements that provide key medical solutions to the patient."

Dr. Wayne Rowe, Director of Sanofi’s iAwards Program